↓ Skip to main content

Cochrane Database of Systematic Reviews

Botulinum toxin injections for adults with overactive bladder syndrome

Overview of attention for article published in this source, December 2011
Altmetric Badge

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
1 tweeter
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
124 Mendeley
Title
Botulinum toxin injections for adults with overactive bladder syndrome
Published by
John Wiley & Sons, Ltd, December 2011
DOI 10.1002/14651858.cd005493.pub3
Pubmed ID
Authors

Duthie, James B, Vincent, Michael, Herbison, G Peter, Wilson, David Iain, Wilson, Don

Abstract

Overactive bladder syndrome (OAB) is a common condition with a significant negative impact on quality of life characterised by urgency with or without urge incontinence, frequency and nocturia.  Intravesical botulinum toxin is being increasingly used to treat severe overactive bladder refractory to standard management.  An increasing body of literature is forming that supports this technique as effective, well tolerated, and safe.  This review is a substantial update of the 2007 review of the same title.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Belgium 1 <1%
Brazil 1 <1%
Unknown 121 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 18%
Student > Bachelor 15 12%
Researcher 14 11%
Student > Ph. D. Student 14 11%
Other 11 9%
Other 28 23%
Unknown 20 16%
Readers by discipline Count As %
Medicine and Dentistry 66 53%
Nursing and Health Professions 6 5%
Agricultural and Biological Sciences 5 4%
Psychology 5 4%
Engineering 4 3%
Other 13 10%
Unknown 25 20%